<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report on a case of a young female soccer player who first experienced a <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> at the age of 21 and then suffered an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> accompanied by <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> 6 months later </plain></SENT>
<SENT sid="1" pm="."><plain>The underlying cause was <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>This clinical picture is caused by a very <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, which interfere with plasmatic coagulation at various sites and are able to activate thrombocytes, endothelial cells, and monocytes </plain></SENT>
<SENT sid="3" pm="."><plain>This leads to a thrombophilic condition with clinical manifestation of recurrent venous thromboses, arterial embolisms, or <z:hpo ids='HP_0001622'>premature birth</z:hpo> or <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriage</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The main therapeutic options are thus anticoagulation, <z:chebi fb="0" ids="24505">heparins</z:chebi>, and aspirin </plain></SENT>
<SENT sid="5" pm="."><plain>Steroids are recommended for cases of pronounced <z:hpo ids='HP_0001873'>thrombocytopenias</z:hpo>; if treatment fails, <z:chebi fb="1" ids="35705">immunosuppressants</z:chebi> are also advisable </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> should be kept in mind especially in cases of young patients with <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> since the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> can be detected in 10-20% of this patient group and effective therapy after diagnosis lowers the rate of recurrence </plain></SENT>
</text></document>